- Y Diweddaraf sydd Ar Gael (Diwygiedig)
- Gwreiddiol (a wnaed Fel)
Dyma’r fersiwn wreiddiol (fel y’i gwnaed yn wreiddiol). This item of legislation is currently only available in its original format.
Regulation 21
1.—(1) Section 7 of the Act (general provisions as to dealing with medicinal products) is amended as follows.
(2) Subsections (2A) and (2B)(1) are repealed.
(3) After subsection 3A(2) insert the following subsection—
“(3B) The restrictions imposed by subsections (2) and (3) of this section shall not apply where the medicinal product concerned is a homoeopathic medicinal product to which the 2001 Directive applies and which fulfils the conditions laid down in Article 14(1) of that Directive.”.
(4) In subsection (7)(3)—
(a)the definition of “certificate of registration” is repealed; and
(b)in the definition of “homoeopathic medicinal product”, the words “products,” and “or compositions” are repealed.
2. In the Medicines (Labelling) Regulations 1976(4), for paragraph (2) of regulation 1 (citation and scope) substitute the following paragraph—
“(2) Nothing in these Regulations applies to—
(a)a medicinal product for human use to which—
(i)the Medicines for Human Use (Marketing Authorisations Etc.) Regulations 1994(5),
(ii)the Medicines (Homoeopathic Medicinal Products for Human Use) Regulations 1994, or
(iii)the Medicines (Traditional Herbal Medicinal Products for Human Use) Regulations 2005,(6)
apply; or
(b)a medicinal product which is an investigational medicinal product within the meaning of the Medicines for Human Use (Clinical Trials) Regulations 2004(7).”.
3. In the Medicines (Leaflets) Regulations 1977(8), for paragraph (2) of regulation 1 (citation, commencement and scope) substitute the following paragraph—
“(2) Nothing in these Regulations applies to a medicinal product for human use to which—
(a)the Medicines for Human Use (Marketing Authorisations Etc.) Regulations 1994;
(b)the Medicines (Homoeopathic Medicinal Products for Human Use) Regulations 1994; or
(c)the Medicines (Traditional Herbal Medicinal Products for Human Use) Regulations 2005,
apply.”.
4.—(1) The Medicines (Advisory Board on the Registration of Homoeopathic Products) Order 1995(9) is amended as follows.
(2) In regulation 1 (citation, commencement and interpretation), in paragraph (2), in the definition of “homoeopathic medicinal product” omit “products,” and “or compositions”.
(3) In regulation 2 (Advisory Board on the Registration of Homoeopathic Products)—
(a)omit paragraph (1)(b);
(b)in paragraph (2)(a), after “human use” insert “as amended by Directive 2002/98/EC of the European Parliament and of the Council setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components(10), Commission Directive 2003/63/EC amending Directive 2001/83/EC on the Community code relating to medicinal products for human use(11), Directive 2004/24/EC of the European Parliament and of the Council amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use(12) and Directive 2004/27/EC of the European Parliament and of the Council amending Directive 2001/83/EC on the Community code relating to medicinal products for human use(13)”; and
(c)in paragraph (2)(d)—
(i)in head (ii) for “8(3)” substitute “8(2)”, and
(ii)in head (iii) for “suspend or revoke” substitute “suspend, vary or revoke”.
Subsections (2A) and (2B) were inserted by regulation 3(2) of S.I. 1994/276.
Subsection (3A) was inserted by regulation 54 of S.I. 2004/1031.
Subsection (7) was substituted by regulation 2(3) of S.I. 1983/1724 and amended by regulation 2(5) of S.I. 1992/604 and regulation 3(4) of S.I. 1994/276.
S.I. 1976/1726, regulation 1 was amended by regulation 11 and paragraph 3 of Schedule 7 to S.I. 1994/3144, and by regulation 54 and paragraph 6 of Part 2 of Schedule 10 to S.I. 2004/1031.
S.I. 1994/3144, as amended by S.I. 1998/3105, 2000/292, 2001/795, 2002/236 and 542, 2003/2321, 2004/3224, 2005/50 and 1710.
S.I. 2005/2750.
S.I. 2004/1031.
S.I. 1977/1055, regulation 1 was amended by regulation 11 and paragraph 5 of Schedule 7 to S.I. 1994/3144.
OJ No. L33, 8.2.2003, p.30.
OJ No. L159, 27.6.2003, p.46.
OJ No. L136, 30.4.2004, p.85.
OJ No. L136, 30.4.2004, p.34.
Y Diweddaraf sydd Ar Gael (diwygiedig):Y fersiwn ddiweddaraf sydd ar gael o’r ddeddfwriaeth yn cynnwys newidiadau a wnaed gan ddeddfwriaeth ddilynol ac wedi eu gweithredu gan ein tîm golygyddol. Gellir gweld y newidiadau nad ydym wedi eu gweithredu i’r testun eto yn yr ardal ‘Newidiadau i Ddeddfwriaeth’.
Gwreiddiol (Fel y’i Deddfwyd neu y’i Gwnaed): Mae'r wreiddiol fersiwn y ddeddfwriaeth fel ag yr oedd pan gafodd ei deddfu neu eu gwneud. Ni wnaed unrhyw newidiadau i’r testun.
Mae Memoranda Esboniadol yn nodi datganiad byr o ddiben Offeryn Statudol ac yn rhoi gwybodaeth am ei amcan polisi a goblygiadau polisi. Maent yn ceisio gwneud yr Offeryn Statudol yn hygyrch i ddarllenwyr nad oes ganddynt gymhwyster cyfreithiol, ac maent yn cyd-fynd ag unrhyw Offeryn Statudol neu Offeryn Statudol Drafft a gyflwynwyd ger bron y Senedd o Fehefin 2004 ymlaen.
Gallwch wneud defnydd o ddogfennau atodol hanfodol a gwybodaeth ar gyfer yr eitem ddeddfwriaeth o’r tab hwn. Yn ddibynnol ar yr eitem ddeddfwriaeth sydd i’w gweld, gallai hyn gynnwys:
Defnyddiwch y ddewislen hon i agor dogfennau hanfodol sy’n cyd-fynd â’r ddeddfwriaeth a gwybodaeth am yr eitem hon o ddeddfwriaeth. Gan ddibynnu ar yr eitem o ddeddfwriaeth sy’n cael ei gweld gall hyn gynnwys:
liciwch ‘Gweld Mwy’ neu ddewis ‘Rhagor o Adnoddau’ am wybodaeth ychwanegol gan gynnwys